Inventor

LIN SHUQUN

US18 patents

⚠️ This page may combine multiple inventors who share the name “LIN SHUQUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LIN SHUQUN

BRISTOL MYERS SQUIBB CO

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Fused heterocyclic compounds useful as kinase modulators

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Heterocyclic amide compounds useful as kinase inhibitors

Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors

Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors

Phenyl-substituted pyrimidine compounds useful as kinase inhibitors

Tricyclic heterocyclic compounds useful as inhibitors of TNF

WROBLESKI STEPHEN T

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Heterocyclic amide compounds useful as kinase inhibitors

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

TEXAS BIOTECHNOLOGY CORP

N, N-disubstituted amides that inhibit the binding of integrins to their receptors

Compounds that inhibit the binding of integrins to their receptors

TEXAS BIOTECHNOLOGY CORP INC

Compounds that inhibit the binding of integrins to their receptors